Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

INDIVIOR INC.

Filed by CROSSROADS STRATEGIES, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-24 06:26:08 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Report
Posted
Jan 19, 2026
Income
$50,000.00
Expenses
Not reported
Filing UUID
6a2346e4-2756-422f-b05a-4272148417df
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Issues related to overdose reversal products including Naloxone; FY2026 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.5304/S.2587); FY2026 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.5342/S.2354).

Literal federal measure citations: H.R.5304, S.2587, H.R.5342, S.2354

MMM · Medicare/Medicaid

Medicaid policies related to substance use disorder.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.